00000000|MMI|177.87|Deep Vein Thrombosis|C0149871|[dsyn]|["DVT NOS"-tx-24-"DVT"-noun-1,"DVT NOS"-tx-23-"DVT"-noun-0,"DVT NOS"-tx-16-"DVT"-noun-1,"DVT NOS"-tx-15-"DVT"-noun-0,"DVT NOS"-tx-9-"DVT"-noun-0,"DVT NOS"-tx-3-"DVT"-noun-0,"DVT NOS"-tx-3-"dvt"-noun-0,"DVT NOS"-tx-3-"dvt"-noun-1,"DVT NOS"-tx-1-"dvt"-noun-0]|TX|3378/3;3269/3;2836/3;2712/3;2498/3;2097/3;[1598/3],[1681/3];[1598/3],[1681/3];64/3|C14.907.355.830.925
00000000|MMI|177.23|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-17-"sc"-noun-0,"SC"-tx-3-"SC"-noun-0]|TX|2876/2;[761/2],[813/2],[878/2],[941/2],[984/2],[1027/2],[1070/2],[1114/2]|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|101.70|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-28-"DISCHARGE"-noun-0,"Discharge"-tx-27-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|3714/9;3572/9;1612/9;166/9;264/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|79.46|Prednisone|C0032952|[horm,orch,phsu]|["PREDNISONE"-tx-26-"prednisone"-noun-0,"PREDNISONE"-tx-19-"prednisone"-noun-0,"PREDNISONE"-tx-13-"prednisone"-noun-0,"PREDNISONE"-tx-3-"PREDNISONE"-noun-0]|TX|3528/10;2970/10;2597/10;1194/10|D04.808.745.432.719.702
00000000|MMI|78.45|Regular Insulin, Human|C0795635|[aapp,horm,phsu]|["INSULIN HUMAN"-tx-3-"INSULIN HUMAN"-noun-0]|TX|[772/13],[824/13],[840/7,856/5]|D06.472.699.587.200.500.625.500;D12.644.548.586.200.500.625.500
00000000|MMI|69.22|Pseudogout|C0033802|[dsyn]|["Pseudo-gout"-tx-12-"Pseudo-gout"-noun-0,"Pseudo-gout"-tx-10-"pseudo-gout"-noun-0,"Pseudo-gout"-tx-3-"pseudogout"-noun-0,"Pseudo-gout"-tx-3-"pseudogout"-noun-1,"Pseudo-gout"-tx-1-"pseudogout"-noun-0]|TX|2575/11;2552/11;[1585/10],[1687/10];[1585/10],[1687/10];70/10|C05.550.114.264
00000000|MMI|67.04|Lesotho|C0023376|[geoa]|["LT"-tx-3-"lt"-noun-0,"LT"-tx-2-"lt"-noun-0]|TX|[916/2],[1129/2];[600/2],[611/2]|Z01.058.290.175.400
00000000|MMI|59.19|District of Columbia|C0012764|[geoa]|["D.C."-tx-7-"d/c"-noun-0,"D.C."-tx-5-"d/c"-noun-0,"D.C."-tx-1-"D/C"-noun-0]|TX|2354/3;2287/3;343/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|54.24|Togo|C0040363|[geoa]|["TO"-tx-26-"to"-adv-0,"TO"-tx-7-"to"-adv-0,"TO"-tx-3-"TO"-adv-0]|TX|3491/2;2406/2;1503/2|Z01.058.290.190.800
00000000|MMI|54.24|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-26-"to"-adv-0,"TO"-tx-7-"to"-adv-0,"TO"-tx-3-"TO"-adv-0]|TX|3491/2;2406/2;1503/2|D08.811.520.224.800
00000000|MMI|51.65|Anti-Inflammatory Agents, Non-Steroidal|C0003211|[phsu]|["NSAID"-tx-3-"Nsaid's"-noun-0,"NSAID"-tx-3-"nsaid's"-noun-0]|TX|1560/7;1809/7|D27.505.696.663.850.014.040.500;D27.505.954.158.030;D27.505.954.329.030
00000000|MMI|51.40|Portugal|C0032729|[geoa]|["PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|[736/2],[1187/2],[1422/2];[507/2],[559/2]|Z01.542.727
00000000|MMI|49.47|Hydrocephalus, Normal Pressure|C0020258|[dsyn]|["NPH"-tx-20-"nph"-noun-0,"NPH"-tx-3-"NPH"-noun-0]|TX|[3017/3],[3111/3];768/3|C10.228.140.602.750
00000000|MMI|48.95|Lebanon|C0023190|[geoa]|["LE"-tx-25-"LE"-noun-0,"LE"-tx-16-"LE"-noun-0]|TX|[3414/2],[3451/2];2781/2|Z01.252.245.500.450
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-3-"DIAGNOSIS"-noun-0]|TX|[1574/9],[1704/9]|x.x.x.x.x.x.x
00000000|MMI|48.00|Give - dosing instruction imperative|C1947971|[ftcn]|["Give"-tx-3-"Give"-verb-0,"Give"-tx-3-"give"-verb-0]|TX|[1214/4],[1272/4],[1330/4];[924/4],[967/4],[1010/4],[1053/4],[1096/4]|
00000000|MMI|40.43|Ulcer|C0041582|[dsyn]|["ULCER"-tx-4-"ulcer"-noun-0,"ULCER"-tx-3-"ulcer"-noun-0]|TX|[2186/5],[2217/5];[1793/5],[2081/5]|C23.550.891
00000000|MMI|40.16|Calcium pyrophosphate deposition disease|C0553730|[dsyn]|["Pseudogout"-tx-3-"pseudogout"-noun-0,"Pseudogout"-tx-3-"pseudogout"-noun-1,"Pseudogout"-tx-1-"pseudogout"-noun-0]|TX|[1585/10],[1687/10];[1585/10],[1687/10];70/10|C05.550.114.264
00000000|MMI|39.98|United States|C0041703|[geoa]|["U S"-tx-25-"u/"-noun-0,"U S"-tx-24-"u/"-noun-0,"U S"-tx-16-"Follow u"-noun-0]|TX|3454/1,3455/1;3347/1,3348/1;2771/6,2784/1|Z01.107.567.875
00000000|MMI|39.97|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-7-"d/c"-noun-0,"D & C"-tx-5-"d/c"-noun-0,"D & C"-tx-1-"D/C"-noun-0]|TX|2354/3;2287/3;343/3|E04.157.310;E04.950.300.299
00000000|MMI|39.49|Mongolia|C0026410|[geoa]|["MG"-tx-3-"MG"-noun-0,"MG"-tx-2-"MG"-noun-0]|TX|[733/2],[1419/2];504/2|Z01.252.474.651
00000000|MMI|39.47|Rehabilitation therapy|C0034991|[topp]|["Rehab"-tx-26-"rehab"-noun-0,"Rehab"-tx-7-"rehab"-noun-0,"Rehabilitation"-tx-2-"Rehabilitation"-noun-0]|TX|3509/5;2361/5;436/14|E02.831;H02.403.680.600;N02.421.784
00000000|MMI|39.43|Rabbi|C0684010|[prog]|["R."-tx-9-"R"-noun-0,"R."-tx-3-"R"-noun-0]|TX|2487/1;[1977/1],[2095/1]|M01.526.799.500
00000000|MMI|39.36|Data Validation Test Document|C3899446|[inpr]|["DVT"-tx-24-"DVT"-noun-0,"DVT"-tx-23-"DVT"-noun-0,"DVT"-tx-16-"DVT"-noun-0,"DVT"-tx-15-"DVT"-noun-0,"DVT"-tx-9-"DVT"-noun-0,"DVT"-tx-3-"DVT"-noun-0,"DVT"-tx-3-"dvt"-noun-0,"DVT"-tx-1-"dvt"-noun-0]|TX|3378/3;3269/3;2836/3;2712/3;2498/3;2097/3;[1598/3],[1681/3];64/3|
00000000|MMI|39.36|Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal|C2926618|[clna]|["DVT"-tx-24-"DVT"-noun-0,"DVT"-tx-23-"DVT"-noun-0,"DVT"-tx-16-"DVT"-noun-0,"DVT"-tx-15-"DVT"-noun-0,"DVT"-tx-9-"DVT"-noun-0,"DVT"-tx-3-"DVT"-noun-0,"DVT"-tx-3-"dvt"-noun-0,"DVT"-tx-1-"dvt"-noun-0]|TX|3378/3;3269/3;2836/3;2712/3;2498/3;2097/3;[1598/3],[1681/3];64/3|
00000000|MMI|32.94|Gout|C0018099|[dsyn]|["GOUT"-tx-3-"gout"-noun-0,"GOUT"-tx-3-"gout"-noun-1]|TX|[1839/4],[2042/4];[1839/4],[2042/4]|C05.550.114.423;C05.799.414;C16.320.565.798.368;C18.452.648.798.368
00000000|MMI|32.49|Paracentesis|C0034115|[hlca]|["Tap"-tx-13-"tap"-noun-0,"Tap"-tx-10-"tapped"-verb-0]|TX|2630/3;2517/6|E01.370.225.998.329;E02.309.805;E02.800.550;E04.237.667;E04.665.600;E05.200.998.329
00000000|MMI|30.42|Aspirin|C0004057|[orch,phsu]|["ASPIRIN"-tx-3-"Aspirin"-noun-0]|TX|1550/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|30.42|insulin human, isophane|C0795633|[aapp,horm,phsu]|["insulin nph human"-tx-3-"INSULIN NPH HUMAN"-noun-0]|TX|788/17|D06.472.699.587.200.300.200.500;D06.472.699.587.200.500.625.500.500;D12.644.548.586.200.300.200.500;D12.644.548.586.200.500.625.500.500
00000000|MMI|29.46|Needs|C0027552|[qlco]|["Need"-tx-26-"need"-verb-0,"Need"-tx-25-"need"-verb-0]|TX|3486/4;3435/4|N03.349.380.420;N05.300.450
00000000|MMI|28.83|Homo sapiens|C0086418|[humn]|["Human"-tx-3-"HUMAN"-noun-0]|TX|780/5|B01.050.150.900.649.801.400.112.400.400
00000000|MMI|28.08|Secondary to|C0175668|[tmco]|["Secondary to"-tx-23-"secondary to"-adj-0,"Secondary to"-tx-21-"secondary to"-adj-0,"Secondary to"-tx-15-"secondary to"-adj-0,"Secondary to"-tx-4-"secondary to"-adj-0,"Secondary to"-tx-3-"second to"-noun-0,"Secondary to"-tx-3-"secondary to"-adj-0]|TX|3313/12;3146/12;2744/12;[2166/12],[2192/12];1799/9;2061/12|
00000000|MMI|27.21|Biospecimen Domain|C3814390|[inpr]|["BS"-tx-7-"bs"-noun-0,"BS"-tx-3-"BS"-noun-0]|TX|2388/2;[896/2],[912/2],[948/2],[991/2],[1034/2],[1077/2]|
00000000|MMI|27.21|Black Swiss Mouse|C4049076|[mamm]|["BS"-tx-7-"bs"-noun-0,"BS"-tx-3-"BS"-noun-0]|TX|2388/2;[896/2],[912/2],[948/2],[991/2],[1034/2],[1077/2]|
00000000|MMI|27.21|Bug Search Subtest (WPPSI-IV)|C4050217|[inpr]|["BS"-tx-7-"bs"-noun-0,"BS"-tx-3-"BS"-noun-0]|TX|2388/2;[896/2],[912/2],[948/2],[991/2],[1034/2],[1077/2]|
00000000|MMI|26.30|Allopurinol|C0002144|[orch,phsu]|["ALLOPURINOL"-tx-5-"allopurinol"-noun-0,"ALLOPURINOL"-tx-2-"ALLOPURINOL"-noun-0]|TX|2271/11;540/11|D03.438.759.160
00000000|MMI|26.26|Knee|C0022742|[bpoc]|["Knee"-tx-13-"knee"-noun-0,"Knee"-tx-10-"knee"-noun-0]|TX|2637/4;2508/4|A01.378.610.450
00000000|MMI|26.26|Knee joint|C0022745|[bsoj]|["Knee"-tx-13-"knee"-noun-0,"Knee"-tx-10-"knee"-noun-0]|TX|2637/4;2508/4|A02.835.583.475
00000000|MMI|26.13|Heparin|C0019134|[bacs,orch,phsu]|["HEPARIN"-tx-17-"heparin"-noun-0,"HEPARIN"-tx-3-"HEPARIN"-noun-0]|TX|2868/7;743/7|D09.698.373.400
00000000|MMI|24.11|Penicillins|C0030842|[antb,orch]|["PENICILLINS"-tx-3-"Penicillins"-noun-0]|TX|1536/11|D02.065.589.099.750;D02.886.108.750;D03.438.260.825;D03.605.084.737;D04.075.080.875.099.221.750
00000000|MMI|22.61|10%|C3842590|[fndg]|["10%"-tx-28-"10"-fraction-0,"10%"-tx-4-"10"-fraction-0,"10%"-tx-3-"10"-integer-0,"10%"-tx-1-"10"-fraction-0]|TX|3686/2;2133/2;[1101/2],[1277/2],[1416/2];286/2|
00000000|MMI|22.52|Surgical aspects|C0038895|[ftcn]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1911/10|x.x.x.x.x.x.x
00000000|MMI|22.41|Oral|C0442027|[spco]|["Oral"-tx-20-"oral"-adj-0,"PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|3046/4;[736/2],[1187/2],[1422/2];[507/2],[559/2]|
00000000|MMI|22.40|Insulin|C0021641|[aapp,horm,phsu]|["INSULIN"-tx-26-"insulin"-noun-0]|TX|3465/7|D06.472.699.587.200.500.625;D12.644.548.586.200.500.625
00000000|MMI|22.40|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-3-"Treatment"-noun-0]|TX|1766/9|x.x.x.x.x.x.x
00000000|MMI|22.39|insulin, isophane|C0021658|[aapp,horm,phsu]|["Insulin, NPH"-tx-3-"NPH INSULIN"-noun-0]|TX|768/11|D06.472.699.587.200.300.200;D12.644.548.586.200.300.200
00000000|MMI|22.21|EXTL3 wt Allele|C1705631|[gngm]|["REG"-tx-3-"REG"-noun-0,"REG"-tx-3-"reg"-noun-0]|TX|820/3;[937/3],[980/3],[1023/3],[1066/3],[1110/3]|
00000000|MMI|22.21|REG1A gene|C1419333|[gngm]|["REG"-tx-3-"REG"-noun-0,"REG"-tx-3-"reg"-noun-0]|TX|820/3;[937/3],[980/3],[1023/3],[1066/3],[1110/3]|
00000000|MMI|20.95|Colace|C0282139|[orch,phsu]|["Colace"-tx-3-"COLACE"-noun-0]|TX|702/6|D02.241.081.337.759.249
00000000|MMI|20.95|Docusate Sodium|C0243237|[orch,phsu]|["DOCUSATE SODIUM"-tx-3-"DOCUSATE SODIUM"-noun-0]|TX|711/15|D02.241.081.337.759.249
00000000|MMI|20.39|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-3-"htn"-noun-0]|TX|[1862/3],[2036/3]|C14.907.489
00000000|MMI|20.30|Disease|C0012634|[dsyn]|["condition"-tx-27-"CONDITION"-noun-0,"condition"-tx-3-"Conditions"-noun-0]|TX|3582/9;1714/10|C23.550.288
00000000|MMI|19.82|Arthritis|C0003864|[dsyn]|["ARTHRITIS"-tx-3-"arthritis"-noun-0]|TX|[1883/9],[2118/9]|C05.550.114
00000000|MMI|19.36|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-2-"meals"-noun-0]|TX|674/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|19.25|Mississippi (geographic location)|C0026221|[geoa]|["Mississippi"-tx-1-"Mississippi"-noun-0]|TX|233/11|Z01.107.567.875.750.500
00000000|MMI|19.23|Arthralgia|C0003862|[sosy]|["JOINT PAIN"-tx-2-"joint pain"-noun-0]|TX|529/10|C05.550.091;C10.597.617.133;C23.888.592.612.094;F02.830.816.444.350;G11.561.600.810.444.350
00000000|MMI|19.22|Utah|C0042124|[geoa]|["UT"-tx-25-"ut"-noun-0]|TX|3406/2|Z01.107.567.875.760.800
00000000|MMI|19.22|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-2-"ATENOLOL"-noun-0]|TX|565/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|18.15|Daily|C0332173|[tmco]|["QD"-tx-3-"QD"-noun-0,"QD"-tx-2-"QD"-noun-0]|TX|[1225/2],[1283/2],[1340/2],[1425/2];562/2|
00000000|MMI|18.04|Unit|C0439148|[qnco]|["UNITS"-tx-3-"Units"-noun-0]|TX|[931/5],[974/5],[1017/5],[1060/5],[1104/5]|
00000000|MMI|18.04|Unit - NCI Thesaurus Property|C3853603|[ftcn]|["Units"-tx-3-"Units"-noun-0]|TX|[931/5],[974/5],[1017/5],[1060/5],[1104/5]|
00000000|MMI|18.04|Unit of Measure|C1519795|[qnco]|["Units"-tx-3-"Units"-noun-0]|TX|[931/5],[974/5],[1017/5],[1060/5],[1104/5]|
00000000|MMI|17.80|Acetaminophen|C0000970|[orch,phsu]|["ACETAMINOPHEN"-tx-2-"ACETAMINOPHEN"-noun-0]|TX|484/13|D02.065.199.092.040
00000000|MMI|17.80|Glucophage|C0591573|[orch,phsu]|["Glucophage"-tx-21-"glucophage"-noun-0]|TX|3121/10|D02.078.370.141.450
00000000|MMI|17.80|Tylenol|C0699142|[orch,phsu]|["Tylenol"-tx-2-"TYLENOL"-noun-0]|TX|474/7|D02.065.199.092.040
00000000|MMI|16.25|Pain|C0030193|[sosy]|["PAIN"-tx-14-"pain"-noun-0]|TX|2666/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|16.25|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-26-"regimen"-noun-0]|TX|3473/7|E02.183;N05.715.360.775.225
00000000|MMI|16.22|Diabetes Mellitus, Insulin-Dependent|C0011854|[dsyn]|["IDDM"-tx-3-"iddm"-noun-0]|TX|2029/4|C18.452.394.750.124;C19.246.267;C20.111.327
00000000|MMI|16.22|Headache|C0018681|[sosy]|["HEADACHE"-tx-2-"headache"-noun-0]|TX|518/8|C10.597.617.470;C23.888.592.612.441
00000000|MMI|16.14|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-2-"Food/Drug Interaction"-noun-0]|TX|617/21|G07.690.773.968.511
00000000|MMI|16.12|Glipizide|C0017642|[orch,phsu]|["GLIPIZIDE"-tx-3-"GLIPIZIDE"-noun-0]|TX|1401/9|D02.886.590.795.500
00000000|MMI|16.08|Urinalysis|C0042014|[lbpr]|["UA"-tx-22-"Ua"-noun-0]|TX|3212/2|E01.370.225.124.810;E01.370.390.810;E05.200.124.810
00000000|MMI|16.07|Lanthanum|C0023031|[elii]|["La"-tx-1-"La"-noun-0]|TX|218/2|D01.268.558.362.500;D01.552.550.399.500;x.x.x.x
00000000|MMI|16.04|Jordan|C0022418|[geoa]|["JO"-tx-13-"jo"-noun-0]|TX|2642/2|Z01.252.245.500.400
00000000|MMI|15.79|Hold (action)|C1948035|[acty]|["Hold"-tx-3-"HOLD"-verb-0,"Hold"-tx-2-"HOLD"-verb-0]|TX|[1117/4],[1452/4];587/4|
00000000|MMI|15.79|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-3-"HOLD"-verb-0,"Hold"-tx-2-"HOLD"-verb-0]|TX|[1117/4],[1452/4];587/4|
00000000|MMI|15.79|Then|C1883708|[tmco]|["Then"-tx-3-"then"-adv-0]|TX|[1259/4],[1317/4],[1373/4]|
00000000|MMI|15.79|To|C1883351|[qlco]|["To"-tx-26-"to"-adv-0,"To"-tx-7-"to"-adv-0,"To"-tx-3-"TO"-adv-0]|TX|3491/2;2406/2;1503/2|
00000000|MMI|15.79|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-3-"HOLD"-verb-0,"hold"-tx-2-"HOLD"-verb-0]|TX|[1117/4],[1452/4];587/4|
00000000|MMI|15.03|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-3-"lt"-noun-0,"LT"-tx-2-"lt"-noun-0]|TX|[916/2],[1129/2];[600/2],[611/2]|
00000000|MMI|15.03|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-3-"lt"-noun-0,"LT"-tx-2-"lt"-noun-0]|TX|[916/2],[1129/2];[600/2],[611/2]|
00000000|MMI|14.80|Discontinued|C1444662|[fndg]|["D/C"-tx-7-"d/c"-noun-0,"D/C"-tx-5-"d/c"-noun-0,"D/C"-tx-1-"D/C"-noun-1,"DIS"-tx-1-"DIS"-noun-0]|TX|2354/3;2287/3;343/3;85/3|
00000000|MMI|14.76|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-28-"DISCHARGE"-noun-0,"Discharge"-tx-27-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|3714/9;3572/9;1612/9;166/9|
00000000|MMI|14.76|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-28-"DISCHARGE"-noun-0,"Discharge"-tx-27-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|3714/9;3572/9;1612/9;166/9|
00000000|MMI|14.64|Hospitalization|C0019993|[hlca]|["hospitalisation"-tx-5-"hospitalization"-noun-0]|TX|2251/15|E02.760.400;N02.421.585.400
00000000|MMI|14.64|Leukocytes|C0023516|[cell]|["WBC"-tx-11-"WBC"-noun-0]|TX|2566/3|A11.118.637;A15.145.229.637;A15.382.490
00000000|MMI|14.46|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-26-"Pt's"-noun-0,"PT"-tx-25-"pt"-noun-0,"PT"-tx-23-"Pt's"-noun-0,"PT"-tx-4-"pt"-noun-0]|TX|3460/4;3387/2;3264/4;2139/2|
00000000|MMI|14.46|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-26-"Pt's"-noun-0,"PT"-tx-25-"pt"-noun-0,"PT"-tx-23-"Pt's"-noun-0,"PT"-tx-4-"pt"-noun-0]|TX|3460/4;3387/2;3264/4;2139/2|
00000000|MMI|14.43|Ulceration|C3887532|[patf]|["ULCER"-tx-4-"ulcer"-noun-0,"ULCER"-tx-3-"ulcer"-noun-0]|TX|[2186/5],[2217/5];[1793/5],[2081/5]|
00000000|MMI|13.14|Diet|C0012155|[food]|["Diet"-tx-3-"DIET"-noun-0]|TX|1465/4|G07.203.650.240
00000000|MMI|13.10|Ability|C0085732|[orga]|["Able"-tx-14-"able"-adj-0]|TX|2680/4|F02.784.629.131
00000000|MMI|13.08|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-27-"PLAN"-noun-0]|TX|3606/4|C10.228.140.744
00000000|MMI|13.07|Weight Bearing|C0085086|[fndg]|["weight bear"-tx-14-"weight bear"-verb-0]|TX|2688/11|G01.374.676.965;G01.595.540.965
00000000|MMI|13.07|Weight-Bearing state|C1318107|[orga]|["weight bear"-tx-14-"weight bear"-verb-0]|TX|2688/11|G01.374.676.965;G01.595.540.965
00000000|MMI|13.06|Honduras|C0019905|[geoa]|["HO"-tx-3-"HO"-noun-0]|TX|890/2|Z01.107.169.534
00000000|MMI|13.03|Stomach|C0038351|[bpoc]|["STOMACH"-tx-2-"stomach"-noun-0]|TX|692/7|A03.556.875.875
00000000|MMI|13.02|Thailand|C0039725|[geoa]|["TH"-tx-4-"TH"-noun-0]|TX|2155/2|Z01.252.145.841
00000000|MMI|13.02|Thallium|C0039738|[elii]|["Th"-tx-4-"TH"-noun-0]|TX|2155/2|D01.268.556.847;D01.552.544.847;x.x.x.x
00000000|MMI|12.94|Dietary Supplements|C0242295|[food]|["Supplement"-tx-20-"supplemented"-adj-0]|TX|3092/12|G07.203.300.456;J02.500.456
00000000|MMI|12.92|Ukraine|C0041580|[geoa]|["UA"-tx-22-"Ua"-noun-0]|TX|3212/2|Z01.542.248.960;Z01.586.200.960;Z01.586.950.960
00000000|MMI|12.89|ARID1A protein, human|C0675390|[aapp,bacs]|["hELD"-tx-21-"held"-adj-0]|TX|3141/4|x.x.x.x
00000000|MMI|12.89|iodonitrotetrazolium|C0063789|[orch]|["INT"-tx-13-"int"-noun-0]|TX|2645/3|x.x.x.x
00000000|MMI|11.79|Order (action)|C1705178|[acty]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3724/6;347/5;176/6|
00000000|MMI|11.79|Order (arrangement)|C1705176|[qlco]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3724/6;347/5;176/6|
00000000|MMI|11.79|Order (document)|C1705175|[inpr]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3724/6;347/5;176/6|
00000000|MMI|11.79|Order (taxonomic)|C1705177|[clas]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3724/6;347/5;176/6|
00000000|MMI|11.79|Permutation|C1882348|[qlco]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3724/6;347/5;176/6|
00000000|MMI|11.79|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-28-"ORDERS"-verb-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|3724/6;347/5;176/6|
00000000|MMI|11.49|Cauterization - action|C0007471|[topp]|["cauterized"-tx-4-"cauterized"-verb-0]|TX|2227/10|E02.154;E04.014.170
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-3-"Complications"-noun-0]|TX|1740/13|x.x.x
00000000|MMI|11.49|Edema|C0013604|[fndg]|["SWELLING"-tx-6-"swelling"-noun-0]|TX|2336/8|C23.888.277
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-3-"PROCEDURES"-noun-0]|TX|1926/10|x.x.x
00000000|MMI|11.30|Hospital admission|C0184666|[hlca]|["admitted"-tx-8-"admitted"-verb-0,"Admission"-tx-3-"Admission"-noun-0,"Admit"-tx-3-"ADMIT"-verb-0]|TX|2426/8;1669/9;1568/5|
00000000|MMI|11.29|milligram/day|C0439422|[qnco]|["mg day"-tx-3-"mg day"-noun-0]|TX|[1222/2,1232/3],[1280/2,1290/3],[1337/2,1347/3]|
00000000|MMI|11.13|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-7-"d/c"-noun-0,"D.C."-tx-5-"d/c"-noun-0,"D.C."-tx-1-"D/C"-noun-0]|TX|2354/3;2287/3;343/3|
00000000|MMI|10.98|Negation|C1518422|[ftcn]|["Not"-tx-25-"not"-adv-0,"Non"-tx-3-"non"-adj-0,"Not"-tx-3-"NOT"-adv-0]|TX|3431/3;1819/3;1968/3|
00000000|MMI|10.81|Therapeutic procedure|C0087111|[topp]|["TREAT"-tx-17-"Treat"-verb-0,"Therapeutic"-tx-13-"therapeutic"-adj-0,"Treatment"-tx-3-"Treatment"-noun-0]|TX|2842/5;2618/11;1766/9|E02
00000000|MMI|10.76|Tapering - action|C0441640|[hlca]|["Taper"-tx-19-"taper"-noun-0,"Taper"-tx-13-"taper"-noun-0,"Taper"-tx-3-"Taper"-noun-0]|TX|2981/5;2608/5;1205/5|
00000000|MMI|10.72|Management procedure|C1273870|[ocac]|["Managed"-tx-23-"managed"-adj-0,"Managed"-tx-20-"managed"-adj-0,"Management"-tx-8-"management"-noun-0]|TX|3282/7;3006/7;2458/10|
00000000|MMI|10.66|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-3-"MG"-noun-0,"Mg++"-tx-2-"MG"-noun-0]|TX|[733/2],[1419/2];504/2|
00000000|MMI|10.66|Milligram percent|C1960952|[qnco]|["mg %"-tx-3-"MG"-noun-0,"mg %"-tx-2-"MG"-noun-0]|TX|[733/2],[1419/2];504/2|
00000000|MMI|10.66|mg/dL|C0439269|[qnco]|["mg%"-tx-3-"MG"-noun-0,"mg%"-tx-2-"MG"-noun-0]|TX|[733/2],[1419/2];504/2|
00000000|MMI|10.59|R prime|C2603358|[clna]|["R'"-tx-9-"R"-noun-0,"R'"-tx-3-"R"-noun-0]|TX|2487/1;[1977/1],[2095/1]|
00000000|MMI|10.59|Right|C0205090|[spco]|["R-"-tx-9-"R"-noun-0,"R-"-tx-3-"R"-noun-0]|TX|2487/1;[1977/1],[2095/1]|
00000000|MMI|10.53|Recent|C0332185|[tmco]|["Recent"-tx-23-"recent"-adj-0,"Recent"-tx-15-"recent"-adj-0,"Recent"-tx-3-"recent"-adj-0]|TX|3326/6;2757/6;2049/6|
00000000|MMI|10.50|HPS4 gene|C1423767|[gngm]|["LE"-tx-25-"LE"-noun-0,"LE"-tx-16-"LE"-noun-0]|TX|[3414/2],[3451/2];2781/2|
00000000|MMI|10.50|LE, Rat Strain|C2697858|[mamm]|["LE"-tx-25-"LE"-noun-0,"LE"-tx-16-"LE"-noun-0]|TX|[3414/2],[3451/2];2781/2|
00000000|MMI|10.50|Less Than or Equal to|C0439090|[qnco]|["LE"-tx-25-"LE"-noun-0,"LE"-tx-16-"LE"-noun-0]|TX|[3414/2],[3451/2];2781/2|
00000000|MMI|10.44|0%|C3842591|[fndg]|["0%"-tx-3-"0"-integer-0]|TX|[929/1],[972/1],[1015/1]|
00000000|MMI|10.42|Affecting|C0392760|[ftcn]|["Affected"-tx-26-"affected"-verb-0,"Affecting"-tx-3-"affecting"-verb-0]|TX|3550/8;1756/9|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-3-"DIAGNOSIS"-noun-0,"DIAGNOSIS"-tx-3-"DIAGNOSIS"-noun-1]|TX|[1574/9],[1704/9];[1574/9],[1704/9]|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-3-"DIAGNOSIS"-noun-0]|TX|[1574/9],[1704/9]|
00000000|MMI|10.42|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-27-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|3672/3;418/3|
00000000|MMI|10.42|Involvement with|C1314939|[ftcn]|["Affected"-tx-26-"affected"-verb-0,"Affecting"-tx-3-"affecting"-verb-0]|TX|3550/8;1756/9|
00000000|MMI|10.42|Patient need for (contextual qualifier)|C0686904|[ftcn]|["need"-tx-26-"need"-verb-0,"need"-tx-25-"need"-verb-0]|TX|3486/4;3435/4|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-28-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|3724/6;176/6|
00000000|MMI|9.99|Diet therapy|C0012159|[hlca]|["Diet"-tx-3-"DIET"-noun-0]|TX|1465/4|E02.642.249
00000000|MMI|9.99|Disease Management|C0376636|[hlca]|["management"-tx-8-"management"-noun-0]|TX|2458/10|N04.590.607
00000000|MMI|9.94|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|1527/7|H02.403.044
00000000|MMI|9.81|Hyperuricemia|C0740394|[dsyn]|["HYPERURICEMIA"-tx-3-"hyperuricemia"-noun-0]|TX|1848/13|C23.550.449
00000000|MMI|9.81|Nonprofit Organizations|C0029247|[orgt]|["NPO"-tx-3-"npo"-noun-0]|TX|1461/3|N03.540.630
00000000|MMI|9.78|Rehabilitation aspects|C0034992|[ftcn]|["Rehabilitation"-tx-2-"Rehabilitation"-noun-0]|TX|436/14|x.x.x
00000000|MMI|9.75|utilization qualifier|C0042153|[ftcn]|["use"-tx-4-"use"-noun-0]|TX|2211/3|x.x.x
00000000|MMI|9.74|Kidney|C0022646|[bpoc]|["Renal"-tx-21-"renal"-adj-0]|TX|3159/5|A05.810.453
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-3-"Infections"-noun-0]|TX|1727/10|C01.539
00000000|MMI|8.34|Work|C0043227|[ocac]|["Work"-tx-3-"WORK"-verb-0]|TX|1506/4|I03.946
00000000|MMI|8.00|Show|C1547282|[anim]|["Show"-tx-24-"shown"-verb-0,"Show"-tx-16-"shown"-verb-0]|TX|3356/5;2810/5|
00000000|MMI|7.61|Condition|C0348080|[qlco]|["Condition"-tx-27-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|3582/9;1714/10|
00000000|MMI|7.61|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-27-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|3582/9;1714/10|
00000000|MMI|7.61|Logical Condition|C1705253|[cnce]|["Condition"-tx-27-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|3582/9;1714/10|
00000000|MMI|7.42|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-3-"Not Applicable"-adj-0,"NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|1512/14;323/14|
00000000|MMI|7.42|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-3-"Not Applicable"-adj-0,"Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|1512/14;323/14|
00000000|MMI|7.38|Structure of right knee|C0230431|[bpoc]|["R knee"-tx-14-"R knee"-noun-0,"R knee"-tx-6-"R knee"-noun-0]|TX|2703/6;2310/6|
00000000|MMI|7.32|Instruction [Publication Type]|C0302828|[inpr]|["instructions"-tx-3-"Instructions"-noun-0,"Instruction"-tx-2-"Instruction"-noun-0]|TX|1136/12;639/11|
00000000|MMI|7.32|Instructions|C1442085|[idcn]|["Instructions"-tx-3-"Instructions"-noun-0,"instruction"-tx-2-"Instruction"-noun-0]|TX|1136/12;639/11|
00000000|MMI|7.31|Treating|C1522326|[ftcn]|["Treat"-tx-17-"Treat"-verb-0,"Treatment"-tx-3-"Treatment"-noun-0]|TX|2842/5;1766/9|
00000000|MMI|7.28|Admission activity|C0809949|[hlca]|["Admitted"-tx-8-"admitted"-verb-0,"Admission"-tx-3-"Admission"-noun-0]|TX|2426/8;1669/9|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-27-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|3624/7;372/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-27-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|3624/7;372/7|
00000000|MMI|7.26|Glucotrol XL|C0720679|[orch,phsu]|["Glucotrol XL"-tx-20-"Glucotrol XL"-noun-0,"Glucotrol XL"-tx-3-"GLUCOTROL XL"-noun-0]|TX|3060/12;1386/12|
00000000|MMI|7.23|Nonsteroidal Anti-inflammatory Drug [EPC]|C3536840|[phsu]|["NSAID"-tx-3-"Nsaid's"-noun-0,"NSAID"-tx-3-"nsaid's"-noun-0]|TX|1560/7;1809/7|
00000000|MMI|7.23|Entire knee region|C1283838|[blor]|["Knee"-tx-13-"knee"-noun-0,"Knee"-tx-10-"knee"-noun-0]|TX|2637/4;2508/4|
00000000|MMI|7.23|Knee region structure|C1963703|[blor]|["Knee, NOS"-tx-13-"knee"-noun-0,"Knee, NOS"-tx-10-"knee"-noun-0]|TX|2637/4;2508/4|
00000000|MMI|7.20|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-8-"PUO"-noun-0,"puo"-tx-1-"PUO"-noun-0]|TX|2442/3;12/3|
00000000|MMI|7.17|Extension|C0231448|[ftcn]|["Extension"-tx-24-"extension"-noun-0,"Extension"-tx-16-"extension"-noun-0]|TX|3365/9;2819/9|
00000000|MMI|7.17|Telephone Extension Number|C1880641|[cnce]|["Extension"-tx-24-"extension"-noun-0,"Extension"-tx-16-"extension"-noun-0]|TX|3365/9;2819/9|
00000000|MMI|7.09|+5|C0728893|[qnco]|["+5"-tx-3-"5"-fraction-0,"+5"-tx-3-"5"-integer-0]|TX|[1243/1],[1335/1];[1243/1],[1335/1]|
00000000|MMI|7.09|>5|C0439084|[qnco]|[">5"-tx-3-"5"-fraction-0,">5"-tx-3-"5"-integer-0]|TX|[1243/1],[1335/1];[1243/1],[1335/1]|
00000000|MMI|7.09|heparin, porcine|C0770546|[bacs,orch,phsu]|["HEPARIN"-tx-17-"heparin"-noun-0,"HEPARIN"-tx-3-"HEPARIN"-noun-0]|TX|2868/7;743/7|
00000000|MMI|7.07|100%|C3817553|[qnco]|["100%"-tx-3-"100"-integer-0,"100%"-tx-2-"100"-integer-0]|TX|729/3;552/3|
00000000|MMI|6.99|FST wt Allele|C3814419|[gngm]|["FS"-tx-3-"fs"-noun-0]|TX|[1126/2],[1163/2]|
00000000|MMI|6.99|French Southern Territories|C1517317|[geoa]|["FS"-tx-3-"fs"-noun-0]|TX|[1126/2],[1163/2]|
00000000|MMI|6.93|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-14-"now"-adv-0,"Now"-tx-3-"now"-adv-0]|TX|2671/3;2087/3|
00000000|MMI|6.79|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-3-"ALLERGY"-noun-1]|TX|1527/7|C20.543
00000000|MMI|6.79|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-3-"ALLERGY"-noun-1]|TX|1527/7|C20.543
00000000|MMI|6.76|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-2-"Instruction"-noun-0]|TX|639/11|I02.903
00000000|MMI|6.63|Periodicals|C0031082|[inpr]|["serial"-tx-24-"Serial"-adj-0]|TX|3340/6|V02.690
00000000|MMI|6.61|Urinary tract|C0042027|[bpoc]|["Urinary"-tx-22-"Urinary"-adj-0]|TX|3198/7|A05.810
00000000|MMI|5.18|1 - 3|C3843504|[fndg]|["1 - 3"-tx-21-"1.3"-real_number-0]|TX|3190/3|
00000000|MMI|5.18|6+11|C3845262|[fndg]|["6+11"-tx-3-"6/11"-fraction-0]|TX|1445/4|
00000000|MMI|5.18|90%|C3842582|[fndg]|["90%"-tx-2-"90"-integer-0]|TX|603/2|
00000000|MMI|5.18|<90|C0439087|[qnco]|["<90"-tx-2-"90"-integer-0]|TX|603/2|
00000000|MMI|5.18|>90|C0439083|[qnco]|[">90"-tx-2-"90"-integer-0]|TX|603/2|
00000000|MMI|5.18|Acetaminophen [EPC]|C2917659|[phsu]|["Acetaminophen"-tx-2-"ACETAMINOPHEN"-noun-0]|TX|484/13|
00000000|MMI|5.18|Additional comments|C1830770|[fndg]|["Additional comments"-tx-23-"ADDITIONAL COMMENTS"-noun-0]|TX|3243/19|
00000000|MMI|5.18|Blood glucose increased|C0595877|[fndg]|["elevated blood sugars"-tx-19-"elevated blood sugars"-noun-0]|TX|2935/21|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-3-"Complications"-noun-0]|TX|1740/13|
00000000|MMI|5.18|Control function|C2587213|[ftcn]|["Control"-tx-7-"control"-verb-0]|TX|2409/7|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|133/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|133/14|
00000000|MMI|5.18|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|423/11|
00000000|MMI|5.18|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|423/11|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-3-"PROCEDURES"-noun-0]|TX|1926/10|
00000000|MMI|5.18|MRC1 gene|C1417249|[gngm]|["MR"-tx-18-"Mr"-noun-0]|TX|2905/2|
00000000|MMI|5.18|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-18-"DM"-noun-0]|TX|2901/2|
00000000|MMI|5.18|Minor Response|C4050513|[fndg]|["MR"-tx-18-"Mr"-noun-0]|TX|2905/2|
00000000|MMI|5.18|Mr. - Title|C2347167|[cnce]|["Mr."-tx-18-"Mr"-noun-0]|TX|2905/2|
00000000|MMI|5.18|Pain in elbow|C0239266|[sosy]|["ELBOW PAIN"-tx-6-"elbow pain"-noun-0]|TX|2321/10|
00000000|MMI|5.18|Percent in White Blood Count Differential|C1882326|[qnco]|["% WBC"-tx-11-"WBC"-noun-0]|TX|2566/3|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-3-"PROCEDURES"-noun-0]|TX|1926/10|
00000000|MMI|5.18|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-3-"RETURN"-verb-0]|TX|1496/6|
00000000|MMI|5.18|Scientific Control|C1882979|[cnce]|["Control"-tx-7-"control"-verb-0]|TX|2409/7|
00000000|MMI|5.18|Sugars|C0242209|[orch,phsu]|["Sugars"-tx-26-"sugars"-noun-0]|TX|3563/6|D09
00000000|MMI|5.18|Swelling|C0038999|[fndg]|["SWELLING"-tx-6-"swelling"-noun-0]|TX|2336/8|
00000000|MMI|5.18|Take|C1515187|[hlca]|["Take"-tx-2-"Take"-verb-0]|TX|651/4|
00000000|MMI|5.18|Treatment intent|C1292734|[ftcn]|["TREAT"-tx-17-"Treat"-verb-0]|TX|2842/5|
00000000|MMI|5.18|True Control Status|C3274648|[qlco]|["Control"-tx-7-"control"-verb-0]|TX|2409/7|
00000000|MMI|5.18|control aspects|C0243148|[qlco]|["control"-tx-7-"control"-verb-0]|TX|2409/7|
00000000|MMI|5.18|control substance|C1550141|[sbst]|["Control"-tx-7-"control"-verb-0]|TX|2409/7|
00000000|MMI|5.18|elevated random blood glucose level|C2703060|[lbtr]|["elevated blood sugars"-tx-19-"elevated blood sugars"-noun-0]|TX|2935/21|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-3-"TREATMENTS/PROCEDURES"-noun-0]|TX|1944/21|
00000000|MMI|3.75|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-2-"DISCHARGE MEDICATIONS"-noun-0]|TX|451/21|
00000000|MMI|3.70|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-3-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1602/9,1622/9|
00000000|MMI|3.70|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-3-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1602/9,1622/9|
00000000|MMI|3.68|Administration occupational activities|C0001554|[ocac]|["Management"-tx-8-"management"-noun-0]|TX|2458/10|
00000000|MMI|3.68|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|91/14|
00000000|MMI|3.68|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|385/9|
00000000|MMI|3.68|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|385/9|
00000000|MMI|3.68|Basal Diet|C2983588|[food]|["DIET"-tx-3-"DIET"-noun-0]|TX|1465/4|
00000000|MMI|3.68|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|91/14|
00000000|MMI|3.68|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-3-"DIET"-noun-0]|TX|1465/4|
00000000|MMI|3.68|FABP6 protein, human|C1435727|[aapp,bacs]|["GT"-tx-3-"gt"-noun-0]|TX|900/2|
00000000|MMI|3.68|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-3-"Instructions"-noun-0]|TX|1136/12|
00000000|MMI|3.68|Management Occupations|C3273539|[ocdi]|["Management"-tx-8-"management"-noun-0]|TX|2458/10|
00000000|MMI|3.68|Palmyra Atoll|C4053562|[geoa]|["XL"-tx-3-"XL"-noun-0]|TX|1411/2|
00000000|MMI|3.68|Respiratory Domain|C2986904|[idcn]|["RE"-tx-20-"re"-verb-0]|TX|3077/2|
00000000|MMI|3.68|Retinol equivalents|C0556581|[qnco]|["{RE}"-tx-20-"re"-verb-0]|TX|3077/2|
00000000|MMI|3.68|SS, Rat Strain|C2699257|[mamm]|["SS"-tx-20-"ss"-noun-0]|TX|3029/2|
00000000|MMI|3.68|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-3-"DIET"-noun-0]|TX|1465/4|
00000000|MMI|3.68|Started|C1272689|[qlco]|["Started"-tx-20-"started"-verb-0]|TX|3080/7|
00000000|MMI|3.68|Subject Status Domain|C3891295|[inpr]|["SS"-tx-20-"ss"-noun-0]|TX|3029/2|
00000000|MMI|3.68|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-3-"DISCHARGE DIAGNOSIS"-noun-0]|TX|1612/19|
00000000|MMI|3.65|Decreased Coagulation Activity [PE]|C3537050|[phsf]|["Anti-coagulation"-tx-23-"anti-coagulation"-noun-0]|TX|3296/16|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|118/13|
00000000|MMI|3.64|Able (finding)|C1299581|[fndg]|["Able"-tx-14-"able"-adj-0]|TX|2680/4|
00000000|MMI|3.64|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|307/10|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-27-"ENTERED"-verb-0]|TX|3632/7|
00000000|MMI|3.63|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|251/7|
00000000|MMI|3.63|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-3-"ALLERGY"-noun-1]|TX|1527/7|
00000000|MMI|3.63|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|1527/7|
00000000|MMI|3.63|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-14-"pain"-noun-0]|TX|2666/4|
00000000|MMI|3.63|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-26-"regimen"-noun-0]|TX|3473/7|
00000000|MMI|3.63|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-3-"ALLERGY"-noun-1]|TX|1527/7|
00000000|MMI|3.63|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|251/7|
00000000|MMI|3.63|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|251/7|
00000000|MMI|3.61|29+|C3843708|[fndg]|["29+"-tx-3-"29"-fraction-0]|TX|1303/2|
00000000|MMI|3.61|4+ Answer to question|C3838679|[fndg]|["4+"-tx-3-"4"-fraction-0]|TX|1301/1|
00000000|MMI|3.61|Planned|C1301732|[ftcn]|["Plan"-tx-27-"PLAN"-noun-0]|TX|3606/4|
00000000|MMI|3.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-27-"PLAN"-noun-0]|TX|3606/4|
00000000|MMI|3.60|Study Day|C2826182|[tmco]|["DY"-tx-3-"dy"-noun-0]|TX|1493/2|
00000000|MMI|3.60|HORNS IN SHEEP|C1832110|[fndg]|["HO"-tx-3-"HO"-noun-0]|TX|890/2|
00000000|MMI|3.60|Healthcare Encounters Domain|C3889614|[inpr]|["HO"-tx-3-"HO"-noun-0]|TX|890/2|
00000000|MMI|3.60|Today|C0310367|[antb,orch]|["Today"-tx-3-"Today"-noun-0]|TX|1437/5|
00000000|MMI|3.60|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-3-"Today"-noun-0]|TX|1437/5|
00000000|MMI|3.59|CDE protocol-cyclophosphamide/doxorubicin/etoposide|C0108844|[topp]|["AVE"-tx-1-"Ave"-noun-0]|TX|221/3|
00000000|MMI|3.59|23|C0450348|[qnco]|["23"-tx-1-"23"-fraction-0]|TX|42/2|
00000000|MMI|3.59|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1911/10|
00000000|MMI|3.59|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1911/10|
00000000|MMI|3.59|Symptoms|C1457887|[sosy]|["SYMPTOMS"-tx-25-"symptoms"-noun-0]|TX|3417/8|
00000000|MMI|3.59|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-25-"symptoms"-noun-0]|TX|3417/8|
00000000|MMI|3.59|Adjustment Action|C0456081|[ftcn]|["Adjusted"-tx-26-"adjusted"-verb-0]|TX|3497/8|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-28-"END"-noun-0]|TX|3707/3|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-3-"Responsible"-adj-0]|TX|1633/11|
00000000|MMI|3.59|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-28-"END"-noun-0]|TX|3707/3|
00000000|MMI|3.57|Empty (qualifier)|C1880497|[qlco]|["Empty"-tx-2-"empty"-adj-0]|TX|686/5|
00000000|MMI|3.57|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-2-"stomach"-noun-0]|TX|692/7|
00000000|MMI|3.57|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-2-"stomach"-noun-0]|TX|692/7|
00000000|MMI|3.57|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-2-"stomach"-noun-0]|TX|692/7|
00000000|MMI|3.56|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-3-"RESUME"-noun-0]|TX|1988/6|
00000000|MMI|3.56|Presentation|C0449450|[idcn]|["Presented"-tx-4-"presented"-verb-0]|TX|2142/9|
00000000|MMI|3.56|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-3-"RESUME"-noun-0]|TX|1988/6|
00000000|MMI|3.56|TH gene|C1420718|[gngm]|["TH"-tx-4-"TH"-noun-0]|TX|2155/2|
00000000|MMI|3.56|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-3-"RESUME"-noun-0]|TX|1988/6|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|356/4|
00000000|MMI|3.55|Agent|C0450442|[chvf]|["Agent"-tx-20-"agent"-noun-0]|TX|3051/5|
00000000|MMI|3.55|Pharmacologic Substance|C1254351|[phsu]|["Agent"-tx-20-"agent"-noun-0]|TX|3051/5|
00000000|MMI|3.55|Protocol Agent|C1521826|[inpr]|["Agent"-tx-20-"agent"-noun-0]|TX|3051/5|
00000000|MMI|3.54|Color of fluid|C0474587|[lbtr]|["fluid color"-tx-10-"colored fluid"-noun-0]|TX|2534/13|
00000000|MMI|3.54|Cereal plant straw|C4047917|[orch]|["Straw"-tx-10-"straw"-adj-0]|TX|2528/5|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-3-"Causing"-adj-0]|TX|1661/7|
00000000|MMI|3.50|Further|C1517331|[spco]|["Further"-tx-8-"further"-adj-0]|TX|2450/7|
00000000|MMI|3.50|NPO - Nothing by mouth|C0419179|[topp]|["NPO"-tx-3-"npo"-noun-0]|TX|1461/3|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|381/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|381/3|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-27-"dictated"-adj-0]|TX|3615/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-27-"dictated"-adj-0]|TX|3615/8|
00000000|MMI|3.49|10 - 19|C3843800|[fndg]|["10 - 19"-tx-1-"10/19"-fraction-0]|TX|107/5|
00000000|MMI|3.48|mg/mg|C1319635|[qnco]|["mg/mg"-tx-2-"MG MG"-noun-0]|TX|556/2,577/2|
00000000|MMI|3.48|Supplement|C2348609|[ftcn]|["Supplement"-tx-20-"supplemented"-adj-0]|TX|3092/12|
00000000|MMI|3.48|Supplement (document)|C1947943|[inpr]|["Supplement"-tx-20-"supplemented"-adj-0]|TX|3092/12|
00000000|MMI|3.48|Administration procedure|C1533734|[topp]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1766/9|
00000000|MMI|3.48|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1766/9|
00000000|MMI|3.48|Insulin Drug Class|C3714501|[horm,phsu]|["INSULIN"-tx-26-"insulin"-noun-0]|TX|3465/7|
00000000|MMI|3.48|Insulin [EPC]|C1579433|[phsu]|["Insulin"-tx-26-"insulin"-noun-0]|TX|3465/7|
00000000|MMI|3.48|Mild (qualifier value)|C2945599|[qlco]|["Minimal"-tx-14-"minimal"-adj-0]|TX|2658/7|
00000000|MMI|3.48|Minimal|C0547040|[qlco]|["Minimal"-tx-14-"minimal"-adj-0]|TX|2658/7|
00000000|MMI|3.48|Minimum|C1524031|[qlco]|["MINIMAL"-tx-14-"minimal"-adj-0]|TX|2658/7|
00000000|MMI|3.48|Recombinant Insulin|C1533581|[aapp,horm,phsu]|["INSULIN"-tx-26-"insulin"-noun-0]|TX|3465/7|
00000000|MMI|3.48|Regular|C0205272|[qlco]|["Regular"-tx-3-"REGULAR"-adj-0]|TX|848/7|
00000000|MMI|3.48|Rehabilitation - specialty|C1306847|[bmod]|["Rehabilitation"-tx-2-"Rehabilitation"-noun-0]|TX|436/14|
00000000|MMI|3.48|Serial Number|C2348188|[inpr]|["SERIAL"-tx-24-"Serial"-adj-0]|TX|3340/6|
00000000|MMI|3.48|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-3-"Treatment"-noun-0]|TX|1766/9|
00000000|MMI|3.48|sliding scale|C2937251|[topp]|["sliding scale"-tx-3-"Sliding Scale"-noun-0]|TX|864/13|
00000000|MMI|3.48|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-3-"Treatment"-noun-0]|TX|1766/9|
00000000|MMI|3.47|Omeprazole 40 MG|C0992678|[clnd]|["Omeprazole 40 MG"-tx-3-"OMEPRAZOLE 40 MG"-noun-0]|TX|1170/16|
00000000|MMI|3.47|Additional|C1524062|[ftcn]|["Additional"-tx-25-"additional"-adj-0]|TX|3440/10|
00000000|MMI|3.47|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|85/3|
00000000|MMI|3.47|Initially|C0205265|[tmco]|["Initially"-tx-20-"initially"-adv-0]|TX|2996/9|
00000000|MMI|3.47|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-27-"Stable"-adj-0]|TX|3593/6|
00000000|MMI|3.47|Primary|C0205225|[qlco]|["Principal"-tx-3-"PRINCIPAL"-adj-0]|TX|1602/9|
00000000|MMI|3.47|RAX gene|C1425688|[gngm]|["RX"-tx-13-"Rx"-noun-0]|TX|2591/2|
00000000|MMI|3.47|Rx therapy|C2709207|[topp]|["Rx"-tx-13-"Rx"-noun-0]|TX|2591/2|
00000000|MMI|3.47|Stable status|C0205360|[qlco]|["STABLE"-tx-27-"Stable"-adj-0]|TX|3593/6|
00000000|MMI|3.47|Teaching principal|C0401925|[prog]|["Principal"-tx-3-"PRINCIPAL"-adj-0]|TX|1602/9|
00000000|MMI|3.46|Hospital course|C0489547|[fndg]|["Hospital course"-tx-3-"HOSPITAL COURSE"-noun-1]|TX|1998/15|
00000000|MMI|3.46|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-3-"HOSPITAL COURSE"-noun-0]|TX|1998/15|
00000000|MMI|3.46|60%|C3842585|[fndg]|["60%"-tx-2-"60"-integer-0]|TX|614/2|
00000000|MMI|3.46|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-3-"ADA"-noun-0]|TX|1479/3|
00000000|MMI|3.46|CA8 gene|C1413051|[gngm]|["CALS"-tx-3-"cals"-noun-0]|TX|1488/4|
00000000|MMI|3.46|Genus Ada|C1060325|[plnt]|["Ada"-tx-3-"ADA"-noun-0]|TX|1479/3|
00000000|MMI|3.46|Home environment|C0442519|[cnce]|["house"-tx-3-"House"-noun-0]|TX|1471/5|
00000000|MMI|3.46|House (environment)|C2003847|[mnob]|["House"-tx-3-"House"-noun-0]|TX|1471/5|
00000000|MMI|3.46|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-3-"cals"-noun-0]|TX|1488/4|
00000000|MMI|3.46|Out (direction)|C0439787|[spco]|["Out"-tx-23-"out"-adv-0]|TX|3292/3|
00000000|MMI|3.46|Peroneal|C0442035|[spco]|["Peroneal"-tx-9-"peroneal"-adj-0]|TX|2489/8|
00000000|MMI|3.46|Removed|C0849355|[qlco]|["Out"-tx-23-"out"-adv-0]|TX|3292/3|
00000000|MMI|3.46|Sint Maarten (Dutch Part)|C3539997|[geoa]|["SX"-tx-22-"sx's"-noun-0]|TX|3206/4|
00000000|MMI|3.46|South Georgia and the South Sandwich Islands|C1519428|[geoa]|["SX"-tx-22-"sx's"-noun-0]|TX|3206/4|
00000000|MMI|3.46|Sustained|C0443318|[ftcn]|["Sustained"-tx-3-"sustained"-adj-0]|TX|1823/9|
00000000|MMI|3.46|Testicular Cancer Serum Markers Test Result SX|C3815196|[lbtr]|["SX"-tx-22-"sx's"-noun-0]|TX|3206/4|
00000000|MMI|3.46|Total abdominal hysterectomy|C0404079|[topp]|["tah"-tx-3-"tah"-noun-0]|TX|1835/3|
00000000|MMI|3.46|kilocalorie|C0439259|[qnco]|["Cal"-tx-3-"cals"-noun-0]|TX|1488/4|
00000000|MMI|3.46|urinary|C1524119|[qlco]|["Urinary"-tx-22-"Urinary"-adj-0]|TX|3198/7|
00000000|MMI|3.46|CDR2 gene|C1413296|[gngm]|["Yo"-tx-3-"yo"-noun-0]|TX|2018/2|
00000000|MMI|3.46|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-3-"Call"-noun-0]|TX|885/4|
00000000|MMI|3.46|Decision|C0679006|[menp]|["Call"-tx-3-"Call"-noun-0]|TX|885/4|
00000000|MMI|3.46|Every four hours|C0585324|[tmco]|["Q4H"-tx-2-"Q4H"-noun-0]|TX|510/3|
00000000|MMI|3.46|HPX wt Allele|C3814444|[gngm]|["HX"-tx-3-"hx"-noun-0]|TX|2026/2|
00000000|MMI|3.46|Joint Pain Adverse Event|C1963066|[fndg]|["Joint pain"-tx-2-"joint pain"-noun-0]|TX|529/10|
00000000|MMI|3.46|M NOS ANTIBODY|C0369637|[aapp,imft]|["M NOS"-tx-3-"M"-noun-0]|TX|2021/1|
00000000|MMI|3.46|M+ (tumor staging)|C0441923|[inpr]|["M+"-tx-3-"M"-noun-0]|TX|2021/1|
00000000|MMI|3.46|Medical History|C0262926|[fndg]|["Hx"-tx-3-"hx"-noun-0]|TX|2026/2|
00000000|MMI|3.46|Precursor B-cell lymphoblastic leukemia|C1292769|[neop]|["c all"-tx-3-"Call"-noun-0]|TX|885/4|
00000000|MMI|3.45|Every morning|C0585329|[tmco]|["QAM"-tx-3-"QAM"-noun-0]|TX|816/3|
00000000|MMI|3.45|Left upper arm structure|C0230347|[bpoc]|["LA"-tx-1-"La"-noun-0]|TX|218/2|
00000000|MMI|3.45|Lupus Anticoagulant Antibody|C2346906|[aapp,imft]|["LA"-tx-1-"La"-noun-0]|TX|218/2|
00000000|MMI|3.45|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-3-"cad"-adj-0]|TX|1869/3|
00000000|MMI|3.45|Neuropathy|C0442874|[dsyn]|["NEUROPATHY"-tx-3-"neuropathy"-noun-0]|TX|1900/10|
00000000|MMI|3.45|Room of building - Study|C0557651|[mnob]|["Study"-tx-3-"Study"-noun-0]|TX|1651/5|
00000000|MMI|3.45|Study|C2603343|[resa]|["Study"-tx-3-"Study"-noun-0]|TX|1651/5|
00000000|MMI|3.45|Checking (action)|C1283174|[acty]|["Check"-tx-3-"check"-noun-0]|TX|1157/5|
00000000|MMI|3.45|Cheque|C1555524|[mnob]|["Cheque"-tx-3-"check"-noun-0]|TX|1157/5|
00000000|MMI|3.45|50%|C3842586|[fndg]|["50%"-tx-2-"50"-integer-0]|TX|574/2|
00000000|MMI|3.45|<50|C3843766|[fndg]|["<50"-tx-2-"50"-integer-0]|TX|574/2|
00000000|MMI|3.44|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-16-"Follow-up"-adj-0]|TX|2771/9|
00000000|MMI|3.44|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-16-"Follow-up"-adj-0]|TX|2771/9|
00000000|MMI|3.44|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-16-"Follow-up"-adj-0]|TX|2771/9|
00000000|MMI|3.44|IFITM1 gene|C1334078|[gngm]|["9-27"-tx-16-"9/27"-fraction-0]|TX|2791/4|
00000000|MMI|3.44|IFITM1 protein, human|C1312248|[aapp,bacs]|["9-27"-tx-16-"9/27"-fraction-0]|TX|2791/4|
00000000|MMI|3.44|IFITM1 wt Allele|C1705676|[gngm]|["9-27"-tx-16-"9/27"-fraction-0]|TX|2791/4|
00000000|MMI|3.44|Usage|C0457083|[ftcn]|["Use"-tx-4-"use"-noun-0]|TX|2211/3|
00000000|MMI|3.44|Use - dosing instruction imperative|C1947944|[inpr]|["Use"-tx-4-"use"-noun-0]|TX|2211/3|
00000000|MMI|3.44|Vioxx|C0876768|[orch,phsu]|["Vioxx"-tx-4-"vioxx"-noun-0]|TX|2205/5|
00000000|MMI|3.44|follow-up|C1522577|[hlca]|["Follow Up"-tx-16-"Follow-up"-adj-0]|TX|2771/9|
00000000|MMI|3.43|Beginning|C0439659|[tmco]|["Start"-tx-3-"Starting"-adj-0]|TX|1428/8|
00000000|MMI|3.43|ARID1A wt Allele|C2985160|[gngm]|["hELD"-tx-21-"held"-adj-0]|TX|3141/4|
00000000|MMI|